MediWound Ltd. (NASDAQ:MDWD), a fully-integrated, biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company has commenced a European post-marketing (Phase 3) Pediatric Investigation Plan (PIP) study to evaluate the efficacy and safety of NexoBrid(R) as a treatment for severe burns in children. MediWound Ltd. (NASDAQ:MDWD) belongs to Healthcare sector. Its weekly performance is -12.01%. On last trading day company shares ended up $5.20. MediWound Ltd. (NASDAQ:MDWD) distance from 50-day simple moving average (SMA50) is -18.49%.

Theravance, Inc. (NASDAQ:THRX) today announced Michael W. Aguiar, President and Chief Executive Officer of Theravance, will be presenting at two upcoming investor conferences in November. Theravance Inc. (NASDAQ:THRX) shares decreased -3.82% in last trading session and ended the day at $14.59. THRX return on assets is -35.70%. Theravance Inc. (NASDAQ:THRX) quarterly performance is -32.95%.

Baidu, Inc. (ADR) (NASDAQ:BIDU) sporting a Zacks Rank #2 (Buy) is a better-performing stock in the technology space that is worth considering. Baidu Inc (ADR) (NASDAQ:BIDU) belongs to Technology sector. Its net profit margin is 29.70% and weekly performance is 5.86%. On last trading day company shares ended up $237.70. Baidu Inc (ADR) (NASDAQ:BIDU) distance from 50-day simple moving average (SMA50) is 8.47%.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) on Nov. 3 reported a third-quarter loss of $10.7 million. The company had a loss of 5 cents per share. The average estimate of analysts was for a loss of 13 cents per share. ARNA posted revenue of $8.2 million in the period, which did not meet Street forecasts. Analysts expected $9.8 million. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is 0.00%. On last trading day company shares ended up $4.26. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is 4.81%.

ATA Inc. (“ATA” or the “Company”) (NASDAQ: ATAI), a leading provider of advanced testing technologies and testing-related services in China, today announced the Company has entered into an agreement to make a strategic investment in Master Mind Education (“Master Mind”), a provider of digitized services to K-12 after-school tutoring institutions in China. ATA, Inc. (NASDAQ:ATAI) shares moved up 2.48% in last trading session and ended the day at $4.14. ATAI Gross Margin is 51.90% and its return on assets is 4.40%. ATA, Inc. (NASDAQ:ATAI) quarterly performance is -7.59%.

GET NOTIFIED
Sign up for our next MicroCap Runner ahead of the crowd!
We hate spam. No Hidden Fees. Unsubscribe Anytime.
Worth Watching Stocks: MediWound Ltd. (NASDAQ:MDWD), Theravance Inc. (NASDAQ:THRX), Baidu Inc (ADR) (NASDAQ:BIDU), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), ATA, Inc. (NASDAQ:ATAI)
Click to comment
To Top